China Internet Healthcare Pivots to AI Chronic Care as 12 Diagnostics Win Reimbursement
Updated
Updated · Healthcare Asia · Jul 16
China Internet Healthcare Pivots to AI Chronic Care as 12 Diagnostics Win Reimbursement
2 articles · Updated · Healthcare Asia · Jul 16
Summary
China's internet healthcare sector is moving away from online drug retail toward AI-enabled chronic disease management, with UOB Kay Hian saying policy and regulatory changes are reshaping growth.
New prescription rules require licensed pharmacists to review online prescriptions, ban AI from prescription checks, enforce a prescription-first model and tighten oversight of third-party platforms.
Those measures are expected to lift compliance costs and curb short-term retail demand, but also accelerate consolidation and favor larger compliant operators such as Ali Health and JD Health.
April's graded diagnosis policy pushes Class III hospitals to shift routine chronic-disease follow-up care to primary providers, strengthening internet hospitals as the main online channel for chronic care.
China also added 12 AI-assisted diagnostics to its Category B reimbursement list, opening reimbursable service fees and supporting platforms expanding into higher-retention, higher-revenue patient management.